TCS surges on partnering with Dassault Systemes to create accurate digital human heart models
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Tata Consultancy Services is currently trading at Rs. 3470.55, up by 27.30 points or 0.79% from its previous closing of Rs. 3443.25 on the BSE.
The scrip opened at Rs. 3451.15 and has touched a high and low of Rs. 3482.00 and Rs. 3445.10 respectively. So far 54594 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 3575.00 on 16-Feb-2023 and a 52 week low of Rs. 2926.00 on 26-Sep-2022.
Last one week high and low of the scrip stood at Rs. 3482.00 and Rs. 3370.05 respectively. The current market cap of the company is Rs. 1271996.03 crore.
The promoters holding in the company stood at 72.30%, while Institutions and Non-Institutions held 22.32% and 5.38% respectively.
Tata Consultancy Services (TCS) has partnered with Dassault Systemes through its Living Heart Project that unites an ecosystem of cardiovascular researchers, educators, medical device developers, regulatory agencies including USFDA, and practicing cardiologists, to develop and validate realistic digital simulations of the human heart. The project will create groundbreaking medical solutions, including the use of heart simulation as a source of digital evidence for new cardiovascular device approvals. This includes an in-silico clinical trial that could complement the evidence drawn from clinical subjects while reducing the need for animal testing and human enrollment for clinical trials.
As an industry partner, TCS will use its domain and technology expertise and its research on the Digital BioTwin of the heart to contribute to model refinement, simulation, and technological implementation in developing and validating highly accurate, personalized digital human heart models. The TCS Digital BioTwin is a biophysics-based high-fidelity computational model developed by TCS’ researchers, to enable investigation of the function of a particular human organ remotely and non-invasively. It helps in understanding the individual contributions of several factors and analyzes their interactions at a spatial scale. TCS has been conducting extensive research in building digital bio-twins of organs such as skin, nose, and colon.
TCS is an IT services, consulting and business solutions organization that has been partnering with many of the world’s largest businesses in their transformation journeys for over 50 years.
